Research Uncovers Method to Weaken Glioblastoma's Treatment Resistance

Scientists have identified a new strategy to combat glioblastoma, an aggressive brain cancer. By blocking the SET protein, researchers prevented tumor formation in preclinical models and made cancer cells more vulnerable to treatment. This discovery offers a novel approach to overcome glioblastoma's resistance to therapies, potentially improving future patient outcomes.